Clinical Trials Update: Feb. 28, 2011 - U.S. News World Report Print
U.S. News & World Report
This study will evaluate Febuxostat in people with gout who have hyperuricemia and moderate-to-severe renal impairment. Male candidates must be 18 or older and females must be 45 or older. This study is for people who have a history of high cholesterol

...